Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T
暂无分享,去创建一个
Claude B. Sirlin | Michael R. Peterson | Tanya Wolfson | Samuel B. Ho | Michael S. Middleton | Yuko Kono | K. Iwaisako | A. Gamst | C. Sirlin | S. Mazhar | M. Peterson | Y. Kono | T. Wolfson | T. Yokoo | H. Mani | Z. Goodman | S. Ho | M. Middleton | Zachary Goodman | Haresh Mani | Christopher Changchien | Anthony C. Gamst | Takeshi Yokoo | Christopher Changchien | Keiko Iwaisako | Sameer M. Mazhar
[1] H. Fujita,et al. Computer-aided diagnosis of hepatic fibrosis: preliminary evaluation of MRI texture analysis using the finite difference method and an artificial neural network. , 2007, AJR. American journal of roentgenology.
[2] Claude B Sirlin,et al. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. , 2006, Radiology.
[3] Shi-Nine Yang,et al. Extracting periodicity of a regular texture based on autocorrelation functions , 1997, Pattern Recognit. Lett..
[4] H. Akaike. A new look at the statistical model identification , 1974 .
[5] P. Bedossa,et al. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .
[6] W. Marsden. I and J , 2012 .
[7] S. Aime,et al. Biodistribution of gadolinium‐based contrast agents, including gadolinium deposition , 2009, Journal of magnetic resonance imaging : JMRI.
[8] Mee Young Park,et al. L1‐regularization path algorithm for generalized linear models , 2007 .
[9] H. Saito,et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.
[10] T. Matsumoto,et al. Hepatic parenchymal enhancement in the cirrhotic liver: evaluation by triple-phase dynamic MRI , 2001, Abdominal Imaging.
[11] T. Schacker,et al. Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.
[12] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[13] Isamu Ohashi,et al. Apparent diffusion coefficient measurements with diffusion‐weighted magnetic resonance imaging for evaluation of hepatic fibrosis , 2005, Journal of magnetic resonance imaging : JMRI.
[14] C. Aubé,et al. Diagnostic et quantification de la fibrose hépatique par IRM de diffusion : résultats préliminaires , 2004 .
[15] Robert M. Haralick,et al. Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..
[16] Mee Young Park,et al. L 1-regularization path algorithm for generalized linear models , 2006 .
[17] Georges Voronoi. Nouvelles applications des paramètres continus à la théorie des formes quadratiques. Deuxième mémoire. Recherches sur les parallélloèdres primitifs. , 1908 .
[18] R. Standish,et al. Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient , 2009, Hepatology.
[19] U. Motosugi,et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. , 2012, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[20] S. L. Murphy,et al. Deaths: final data for 2002. , 2004, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[21] Anil K. Jain,et al. Texture Analysis , 2018, Handbook of Image Processing and Computer Vision.
[22] J. Rockstroh,et al. Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes? , 2010, Current opinion in HIV and AIDS.
[23] P. Marcellin. Hepatitis B and hepatitis C in 2009 , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[24] B. Fleshler,et al. The Liver: Biology and Pathobiology , 1983 .
[25] Daniele Marin,et al. Emerging applications for ferumoxytol as a contrast agent in MRI , 2015, Journal of magnetic resonance imaging : JMRI.
[26] R. Ehman,et al. Magnetic resonance elastography of liver. , 2014, Magnetic resonance imaging clinics of North America.
[27] N. Afdhal,et al. Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.
[28] A. Manduca,et al. Assessment of hepatic fibrosis with magnetic resonance elastography. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] A. Burroughs,et al. Assessment of fibrosis and cirrhosis in liver biopsies: an update. , 2011, Seminars in liver disease.
[30] W. Kim,et al. The global impact of hepatic fibrosis and end-stage liver disease. , 2008, Clinics in liver disease.
[31] Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. , 1994, Hepatology.
[32] D. Thabut,et al. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease , 2002, Comparative hepatology.
[33] S. Kakar,et al. Contributions to Hepatic Fibrosis in HIV-HCV Coinfected and HCV Monoinfected Patients , 2006, The American Journal of Gastroenterology.
[34] E L Murphy,et al. Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.
[35] R. Weissleder,et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. , 1990, Radiology.
[36] Superparamagnetic iron oxide: clinical time-response study. , 1991, European journal of radiology.
[37] A. Gamst,et al. Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast‐enhanced magnetic resonance images , 2012, Journal of magnetic resonance imaging : JMRI.
[38] A. Gabriel,et al. The Comparison of Scoring Scales for Liver Biopsy Assessment in Morbidly Obese Patients Undergoing Bariatric Surgery , 2005, Obesity surgery.
[39] A. Gamst,et al. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis , 2007, Journal of magnetic resonance imaging : JMRI.
[40] B. Bell,et al. Chronic liver disease mortality in the United States, 1990–1998 , 2004, Hepatology.
[41] C. Aubé,et al. [Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results]. , 2004, Journal de radiologie.
[42] Sang Joon Kim,et al. A Mathematical Theory of Communication , 2006 .
[43] M. O'brien,et al. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. , 2000, American journal of clinical pathology.
[44] R. Fisher,et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[45] S. Saini,et al. Liver-specific MR imaging contrast agents. , 1998, Radiologic clinics of North America.
[46] B. V. Van Beers,et al. Liver fibrosis: non‐invasive assessment with MR elastography , 2006, NMR in biomedicine.
[47] Enrico Rossi,et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. , 2003, Clinical chemistry.
[48] P. Deb. Finite Mixture Models , 2008 .
[49] R. Malekzadeh,et al. Reversibility of cirrhosis in chronic hepatitis B. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[50] H. Wilson,et al. Computation of geometrical and inertial properties for general areas and volumes of revolution , 1976 .
[51] Richard L Ehman,et al. MR elastography of the liver: preliminary results. , 2006, Radiology.
[52] J. Hoefs,et al. Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. , 2011, Gastroenterology.
[53] Neil Kaplowitz,et al. Liver biology and pathobiology , 2006, Hepatology.
[54] Richard L Ehman,et al. Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications , 2007, Hepatology.
[55] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[56] M. Tzalonikou,et al. Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging , 2001, Abdominal Imaging.
[57] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[58] P. Thampanitchawong,et al. Liver biopsy:complications and risk factors. , 1999, World journal of gastroenterology.